Open Orphan - New Contract and Directorate Change

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company announces the signing of a new contract with a US biotechnology Company and Cathal Friel, Executive Chairman also announces that Trevor Phillips is standing down as CEO.

Cathal Friel
Executive Chairman

Company Events - OPEN ORPHAN